Advance a novel therapeutic to a first-in-human clinical study

Active Definitive Contract Awarded Last action

Contract number
75N93025C00035
Awardee
Awarding agency
Obligated
$13,166,917

Award facts

Contract value 47% obligated
  • $13,166,917.00 Current, with exercised options
  • $27,811,580.00 Potential, with all options
Completion date 33% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 16 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Morrisville, NC, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00005 $5,271,052
Other Administrative Action P00004 $0
Other Administrative Action P00003 · EO 14398 advance a novel therapeutic to a first-in-human clinical study $0
Exercise an Option P00002 $4,576,910
Original award $3,318,955

About this award

The National Institute of Allergy and Infectious Diseases awarded a $27.8 million definitive contract to Locus Biosciences Inc. on September 24, 2025, to advance a novel therapeutic to a first-in-human clinical study under cost-plus-fixed-fee pricing.

Place of performance is Morrisville, NC. The contract extends through February 7, 2029. No set-aside category was used.

Quick answers

Who was awarded contract 75N93025C00035?

75N93025C00035 was awarded to Locus Biosciences Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 24, 2025.

How much is contract 75N93025C00035 worth?

The government has obligated $13,166,917 on 75N93025C00035. Its potential value, with all options, is $27,811,580.

Was contract 75N93025C00035 competed?

The extent of competition for 75N93025C00035 was full and open competition. The government received 16 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award